KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Short term Debt (2016 - 2026)

Encompass Health (EHC) has disclosed Short term Debt for 18 consecutive years, with $42.9 million as the latest value for Q1 2026.

  • For Q1 2026, Short term Debt fell 69.07% year-over-year to $42.9 million; the TTM value through Mar 2026 reached $42.9 million, down 69.07%, while the annual FY2025 figure was $43.6 million, 68.54% down from the prior year.
  • Short term Debt hit $42.9 million in Q1 2026 for Encompass Health, down from $43.6 million in the prior quarter.
  • Across five years, Short term Debt topped out at $233.0 million in Q3 2024 and bottomed at $22.8 million in Q2 2023.
  • Average Short term Debt over 5 years is $63.2 million, with a median of $39.0 million recorded in 2025.
  • Year-over-year, Short term Debt skyrocketed 874.9% in 2024 and then plummeted 83.26% in 2025.
  • Encompass Health's Short term Debt stood at $25.2 million in 2022, then decreased by 1.59% to $24.8 million in 2023, then surged by 458.87% to $138.6 million in 2024, then crashed by 68.54% to $43.6 million in 2025, then decreased by 1.61% to $42.9 million in 2026.
  • According to Business Quant data, Short term Debt over the past three periods came in at $42.9 million, $43.6 million, and $39.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.